Tencent Reaches Into London's Tech Hub for Parkinson's Partner
This article is for subscribers only.
One of China’s tech mammoths is tapping into the London digital hub for help with using artificial intelligence to improve Parkinson’s disease treatment.
Tencent Holdings Ltd. is teaming with closely held Medopad Ltd. to develop a system to remotely monitor patients with the severe movement disorder. Their goal, according to Wei Fan, executive director for medical AI research at Shenzhen-based Tencent, is to allow doctors to set drug doses and modify care without patients coming into the hospital.